Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hellstern

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Vox Sanguinis|January 1, 1997
Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study GroupP Hellstern, H Beeck, A Fellhauer, et al.
Vox Sanguinis|January 1, 1989
Factor VII half-life after transfusion of a steam-treated prothrombin complex concentrate in a patient with homozygous factor VII deficiencyM Köhler, P Hellstern, G Pindur, et al.
Thrombosis Research|June 15, 1997
Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentratesP Hellstern, H Beeck, A Fellhauer, et al.
Behring Institute Mitteilungen|February 1, 1986
[Fibrinolytic treatment of deep vein thrombosis and lung embolism]P Scheffler, G von Blohn, P Hellstern, et al.
Klinische Wochenschrift|June 1, 1984
The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophiliaM Köhler, P Hellstern, B Reiter, et al.
Blut|July 1, 1984
In vitro characterization of commercial Factor VIII concentrates: long-term follow-upC Miyashita, P Hellstern, M Köhler, et al.
Behring Institute Mitteilungen|February 1, 1986
[Clinical aspects of acquired antithrombin III deficiency]G von Blohn, P Hellstern, M Köhler, et al.
Infusionstherapie Und Transfusionsmedizin|June 1, 1993
Prospective study on efficacy and tolerability of solvent/detergent-treated plasma in intensive care unit patientsP Hellstern, E Larbig, G A Walz, et al.
Thrombosis and Haemostasis|October 6, 1998
Thromboembolic complications associated with the use of prothrombin complex and factor IX concentratesM Köhler, P Hellstern, E Lechler, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|May 15, 1984
[Relevance of antithrombin III in thrombogenesis: the diagnosis and therapy of antithrombin III defects]E Wenzel, P Hellstern, E Dumitrescu-Demma, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Vox Sanguinis|January 1, 1997
Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study GroupP Hellstern, H Beeck, A Fellhauer, et al.
Vox Sanguinis|January 1, 1989
Factor VII half-life after transfusion of a steam-treated prothrombin complex concentrate in a patient with homozygous factor VII deficiencyM Köhler, P Hellstern, G Pindur, et al.
Thrombosis Research|June 15, 1997
Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentratesP Hellstern, H Beeck, A Fellhauer, et al.
Behring Institute Mitteilungen|February 1, 1986
[Fibrinolytic treatment of deep vein thrombosis and lung embolism]P Scheffler, G von Blohn, P Hellstern, et al.
Klinische Wochenschrift|June 1, 1984
The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophiliaM Köhler, P Hellstern, B Reiter, et al.
Blut|July 1, 1984
In vitro characterization of commercial Factor VIII concentrates: long-term follow-upC Miyashita, P Hellstern, M Köhler, et al.
Behring Institute Mitteilungen|February 1, 1986
[Clinical aspects of acquired antithrombin III deficiency]G von Blohn, P Hellstern, M Köhler, et al.
Infusionstherapie Und Transfusionsmedizin|June 1, 1993
Prospective study on efficacy and tolerability of solvent/detergent-treated plasma in intensive care unit patientsP Hellstern, E Larbig, G A Walz, et al.
Thrombosis and Haemostasis|October 6, 1998
Thromboembolic complications associated with the use of prothrombin complex and factor IX concentratesM Köhler, P Hellstern, E Lechler, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|May 15, 1984
[Relevance of antithrombin III in thrombogenesis: the diagnosis and therapy of antithrombin III defects]E Wenzel, P Hellstern, E Dumitrescu-Demma, et al.
Pageof 9